GSK Wellbutrin XL Ad Notes Suicidality Risk, Does Not Reflect “Black Box”
Executive Summary
A new GlaxoSmithKline television ad for the antidepressant Wellbutrin XL includes information about suicidality and mood changes
You may also be interested in...
FDA Takes Relaxed Stance On DTC Ads For Products With “Black Box”
FDA is not requiring the inclusion of the full text of a "black box" warning in new direct-to-consumer advertisements for antidepressants
FDA Takes Relaxed Stance On DTC Ads For Products With “Black Box”
FDA is not requiring the inclusion of the full text of a "black box" warning in new direct-to-consumer advertisements for antidepressants
FDA Awaits More Effexor Data Following U.K. Regulatory Changes
FDA is awaiting further data on Wyeth's Effexor following U.K. regulatory changes for the antidepressant